Noerr-Pennington and the FTC
12 PM EST
For decades, the FTC has sought to circumscribe the Noerr-Pennington doctrine. While recent efforts have been in the pharma space, the FTC’s antipathy can be traced back to the 1980s and has been expressed many times since in reports, closing statements, and briefs. This panel will explore the roots of the FTC’s views and contest recent developments and underlying policy considerations.
FREE: Antitrust Section Members, Government, Non-profit Employees, Students.
$25 Other Non-Members
Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25. For this and all upcoming events visit http://ambar.org/atevents.
The ABA is not seeking CLE credit for this program.
Audio Archive: Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.